Sign in
Not yet taking people in FranceNo phase

Group cognitive rehabilitation for early Parkinson's with thinking concerns

Tests a group thinking-skills program in adults with early Parkinson's and mild thinking problems.

Key facts

Who runs it
University Hospital, Clermont-Ferrand
Where
Clermont-Ferrand, FranceSee the site
Trial code
Registry title
Idiopathic Parkinson's Disease: Interest of an Early Group-Based Cognitive Rehabilitation Program (LIFECOG-PD)
Status
Not yet recruiting
People taking part
24 people, planned
Started
15 Sept 2026
Expected to end
30 Sept 2027
Type of study
Interventional
Treatments tested
  • cognitive rehabilitation program
Record updated
10 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with idiopathic Parkinson's disease who have no cognitive impairment or mild cognitive impairment and an early complaint about their thinking or memory. It tests a group cognitive rehabilitation program.

Age
18 years or older
Sex
Men and women
Disease stage
Idiopathic Parkinson's disease, without dementia. No cognitive impairment, or level 2 mild cognitive impairment as defined by the MDS.
Biomarker or test result
A score between 1 and 8 on the Subjective Cognitive Complaints Questionnaire for Parkinson's Disease (SCCQ-PD).

Main reasons for not taking part

  • Another neurological disorder or an active psychiatric illness, including a severe depressive episode or active psychosis
  • Beck Depression Inventory (BDI-II) score above 21
  • Parkinson's disease dementia
  • Signs of an atypical parkinsonian syndrome
  • Pregnant or breastfeeding women

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • • Men or women ≥18 years old, diagnosed with idiopathic Parkinson's disease according to the official diagnostic criteria defined by the Movement Disorder Society (MDS) ; Without cognitive impairment based on neuropsychological evaluation or meeting level 2 Mild Cognitive Impairment (MCI) criteria defined by the MDS, and presenting an early subjective cognitive complaint defined by a score between 1 and 8 on the Subjective Cognitive Complaints Questionnaire for Parkinson's Disease (SCCQ-PD); Non-demented according to MDS criteria; Ability to understand the protocol; Ability to provide free and informed consent; Patients covered by a social insurance system

Who cannot take part

  • • Any associated neurological disorder or active psychiatric pathology, including severe depressive episode or active psychotic episode. Participants with a Beck Depression Inventory (BDI-II) score above 21 will be excluded from the study and referred to an appropriate healthcare professional for further evaluation and follow-up as needed; Patients meeting the criteria for Parkinson's disease dementia; Any clinical sign suggesting atypical parkinsonian syndrome (ocular motor disorder, cognitive impairment, apraxia, early falls); Pregnant or breastfeeding women; Participants under legal protection measures such as judicial protection, deprivation of liberty, curatorship, or guardianship

Where in France

  • CHU de Clermont-FdClermont-Ferrand, FranceContact: Lise LACLAUTRENot yet recruiting

About the trial

What the trial wants to find out

Current pharmacological treatments have not demonstrated significant improvement in cognitive impairment in Parkinson's disease (PD). Given the high prevalence and serious impact of cognitive impairment in PD, there is a pressing need for non-pharmacological interventions with demonstrated functional benefits. Cognitive rehabilitation is a structured program designed to help improve or compensate for patients' cognitive abilities by providing an approach tailored to each patient's individual needs and goals. Neuropsychologists from French Parkinson's Disease expert centers have developed a new cognitive rehabilitation program called LifeCOG-PD, for PD patients with a subjective cognitive complaint or a mild cognitive impairment (MCI), delivered at the hospital in seven 90-minute sessions conducted in groups of 3-4 participants. This program, combining psychoeducation, practical strategies, and personalized goal setting, aims to maintain patients' daily autonomy, enhance quality of life, and delay the cognitive impact of the disease.

Read full original descriptionShow less

By evaluating feasibility, acceptability and functional outcomes, this study will contribute critical data to inform future PD management guidelines to help support autonomy and cognitive resilience in PD.

The group in the trial

  • cognitive rehabilitation programTreatment being tested

    Patients will receive the new cognitive rehabilitation program.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Idiopathic Parkinson's Disease: Interest of an Early Group-Based Cognitive Rehabilitation Program
Plain-language title
Group cognitive rehabilitation for early Parkinson's with thinking concernsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
10 September 2026